# OnCo record jean-abraham (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/jean-abraham/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "jean-abraham" ;
  schema:name "Jean Abraham"@en ;
  schema:description "Chief investigator of PARTNER, the UK trial of neoadjuvant olaparib with platinum chemotherapy in triple-negative and BRCA-associated breast cancer, run from Addenbrooke's across 23 NHS sites (30 on the ClinicalTrials.gov record)."@en ;
  schema:url <https://onco.cc/people/jean-abraham/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://www.oncology.cam.ac.uk/directory/j-abraham>, <https://www.cam.ac.uk/research/news/new-approach-to-treating-aggressive-breast-cancers-shows-significant-improvement-in-survival> ;
  onco:tag "breast", "trialist", "uk" ;
  schema:jobTitle "Professor of Precision Breast Cancer Medicine and Honorary Consultant in Medical Oncology, University of Cambridge; Director, Precision Breast Cancer Institute; Consultant, Addenbrooke's Hospital" ;
  onco:related <https://onco.cc/people/andrew-tutt/> ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/tnbc-early/> ;
  onco:technologies <https://onco.cc/technologies/parp-inhibitor/>, <https://onco.cc/technologies/platinum/> ;
  onco:targets <https://onco.cc/targets/brca/> ;
  onco:drugs <https://onco.cc/drugs/olaparib/>, <https://onco.cc/drugs/carboplatin/> ;
  onco:institutions <https://onco.cc/institutions/addenbrookes-cambridge/>, <https://onco.cc/institutions/cruk-cambridge-centre/> ;
  onco:trials <https://onco.cc/trials/partner/>, <https://onco.cc/trials/tnt/> ;
  schema:affiliation <https://onco.cc/institutions/addenbrookes-cambridge/> .